Phase III Multicenter Open-label Randomized Clinical Trial Comparing Everolimus and Low Dose Tacrolimus to Tacrolimus and Mycophenolate Mofetil at 6 mo Post-Transplant to Prevent Long-term Complications After Pediatric Heart Transplantation
Latest Information Update: 25 Dec 2023
At a glance
- Drugs Everolimus (Primary) ; Mycophenolate mofetil; Tacrolimus
- Indications Heart transplant rejection
- Focus Adverse reactions; Therapeutic Use
- Acronyms TEAMMATE
- 13 Nov 2023 Results presented at the American Heart Association Scientific Sessions 2023
- 08 Sep 2023 Planned End Date changed from 1 May 2023 to 1 Jan 2024.
- 04 May 2023 Planned primary completion date changed from 1 Apr 2023 to 1 May 2023.